Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Targovax selected for oral presentation at Society for Immunotherapy of Cancer (SITC) 2019 Annual Meeting

Read the release

Title: A pilot study of engineered adenovirus ONCOS-102 in combination
with pembrolizumab in checkpoint inhibitor refractory advanced or
unresectable melanoma
Authors: Alexander N. Shoushtari, MD; Anthony J. Olszanski, MD, RPh; Thomas
J. Hornyak, MD; Jedd D. Wolchok, MD, PhD; Sylvia Vetrhus; Karianne
Risberg Handeland; Lukasz Kuryk, PhD; Magnus Jaderberg, MD;
Date: 9 November 2019
Time: 5:30 pm - 5:45 pm
Presenter: Dr. Alexander Shoushtari, Principal Investigator, MSKCC, NYC

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.